Web25 mar 2009 · Figure S2: (A) Alignment of the promoter immediately upstream of the PCA3 isoform 4 (PCA3-4) transcription start site (arrowed) for different primates.Three overlapping SRY transcription factor consensus binding sites unique to the human promoter (AAACAAA - underlined) are located within the FP2 transcription factor binding footprint described by … WebPatients (mean age 76 years) presented with urinary symptoms and haematuria. Mean serum prostate specific antigen (PSA) was 7.01 ng/mL (range 1.04-21). Single small …
Robot-assisted laparoscopic prostatectomy versus open radical
Web10 giu 2024 · Objective. To evaluate the ability of preoperative multiparametric magnetic resonance imaging (mpMRI) and a gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (68 Ga-PSMA PET/CT) scan to predict pathological outcomes and also identify a group of men with a <5% risk of histological … WebThe median kappa for the classification of atrophy lesions into the 4 subtypes was 0.80. The median percent agreement with the standard diagnosis for the atrophy subtypes were: simple 60.6%, simple with cyst formation 100%; postatrophic hyperplasia 87.5%; partial atrophy 93.9%. The lower percentage for simple atrophy reflected a propensity to ... github on startup
Prostate cancer grading: recent developments and future directions
WebFingerprint Dive into the research topics of 'The critical role of the pathologist in determining eligibility for active survlnc. as a mgmt. option in patients with prostate cancer: Consensus statement with recommendations supported by the Coll. of Amer. Pathologists, Intl. Soc. of Urological Pathol., Assoc. of Directors of Anat. and Surg. Pathol., the New Zealand Soc. … WebAmber J. Willems, Sarah Jane Dawson, Hema Samaratunga, Alessandro De Luca, Yoland C. Antill, John L. Hopper, Heather J. Thorne IRCCS Casa Sollievo della Sofferenza Research output : Contribution to journal › Article › peer-review WebStephens1,2, Jin Gao3, Hema Samaratunga4,5, Australian Prostate Cancer BioResource6, Mitchell G. Lawrence 7 , John D. Hooper 8 , Ying Dong 2 , Gail P. Risbridger 7,9,10 and Judith A. Clements 1,2 1 Australian Prostate Cancer Research Centre – Queensland, Translational Research Institute, Queensland University of Technology (QUT), github onvif